Immunomedics Inc (NASDAQ:IMMU)
| 3.14 Data as of May 17 |  +0.03 / +0.96%Today’s Change | 2.11 Today|||52-Week Range 3.76 | +7.53% Year-to-Date |
Latest IMMU News | Press Releases
No recent news for Immunomedics Inc.
Today’s Trading
| Previous close | 3.11 |
| Today’s open | 3.13 |
| Day’s range | 3.10 - 3.17 |
| Volume | 429,403 |
| Average volume (3 months) | 479,866 |
| Market cap | $259.7M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -3,575.00% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +122.54% |
| P/E ratio | NM |
| Price/Sales | 8.21 |
| Price/Book | 7.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TEARTearLab Corp | +0.76 | +8.09% |
| CUTRCutera Inc | -0.02 | -0.22% |
| ARAYAccuray Inc | +0.11 | +2.14% |
| CYNOCynosure Inc | -0.48 | -1.95% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | August 29, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $32.7M |
| Annual profit (last year) | $810.0K |
| Net profit margin | 2.47% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, Chief Scientific & Medical Officer David M. Goldenberg, MD |
President, Chief Executive Officer & Director Cynthia L. Sullivan, MBA |
Corporate headquarters Morris Plains, New Jersey |
Forecasts
